Tue, December 6, 2022

Terence Flynn Maintained (UTHR) at Buy with Increased Target to $330 on, Dec 6th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-330-on-dec-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Terence Flynn of Morgan Stanley, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $322 to $330 on, Dec 6th, 2022.

Terence has made no other calls on UTHR in the last 4 months.



There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Terence's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Terence


  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Sell and Held Target at $230 on, Monday, December 5th, 2022
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $375 on, Thursday, November 3rd, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $265 on, Thursday, November 3rd, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Thursday, November 3rd, 2022